← Eichor
Study identifier: NCT05532566 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Condition: Allergic Reaction · Allergic Skin Reaction · Allergy Pollen  ·  Sponsor: Inmunotek S.L.

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

The objective of this study is to determine the biological activity of Quercus illex and Quercus robur allergen extracts in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

This description comes directly from the study's public registry record.

Talk to the study team

Miguel Casanovas, MD  ·  +34912908942  ·  mcasanovas@inmunotek.com

Raquel Caballero, BSc  ·  +34607600638  ·  rcaballero@inmunotek.com

Always discuss trial participation with your own doctor first.

Locations (1)

Clínica Subiza, centro de asma y alergiaMadrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05532566